Rocket Pharmaceuticals, Inc. (RCKT) , a stock from Biotechnology Industry, has a value of $21.33 per share, noted a price change of 6.65% in recent trade close.
Annual earnings per share (EPS) growth noted at -16.20% in past 5 Years and The company is estimating to achieve earnings per share (EPS) growth of 32.00% in this year .
The stock has P/B of 3.04. The price-to-book ratio (P/B Ratio) is a ratio used to compare a stock’s market value to its book value. It is calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. A lower P/B ratio could mean that the stock is undervalued. However, it could also mean that something is fundamentally wrong with the company. As with most ratios, be aware that this varies by industry. This ratio also gives some idea of whether you’re paying too much for what would be left if the company went bankrupt immediately.
Analysts mean Recommendation on a stock is noted at 2.00. Analyst Recommendation is an outlook of a stock-market analyst on a stock. Rating Scale: 1.0 represent “Strong Buy” and 2.0 signify “Buy” 3.0 while shows “Hold”. 4.0 display “Sell” and 5.0 reveal “Strong Sell” rating.
The performance for week is 21.06% and the performance for quarter is at 24.08%. The performance for month is 26.14% and the performance for half year is 85.80%. Its monthly volatility value of 5.42% and volatility for the week is valued at 9.72%. The performance for Year to Date (YTD) is 104.31%.
59.40% shares of the company possessed by Institutional Investors. Insiders own 0.60% of Rocket Pharmaceuticals, Inc. (RCKT) shares.
Indicating how profitable this stock is relative to its assets, the ROA value is observed at -34.50%. The ROA tells us exactly what earnings were generated from the invested capital.